Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |